Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,220,574
-
Share change
-
+2,046
-
Total reported value
-
$261,461,306
-
Put/Call ratio
-
77%
-
Price per share
-
$42.01
-
Number of holders
-
83
-
Value change
-
+$86,242
-
Number of buys
-
2
Institutional Holders of FURIEX PHARMACEUTICALS INC - COM (FURX) as of Q4 2013
As of 31 Dec 2013,
FURIEX PHARMACEUTICALS INC - COM (FURX) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,220,574 shares.
The largest 10 holders included
Artal Group S.A., Consonance Capital Management LP, THOMPSON SIEGEL & WALMSLEY LLC, EAGLE ASSET MANAGEMENT INC, ROYCE & ASSOCIATES LLC, GREAT POINT PARTNERS LLC, Visium Asset Management, LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
83
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.